These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18578857)

  • 1. ELR+ CXC chemokine expression in benign and malignant colorectal conditions.
    Rubie C; Frick VO; Wagner M; Schuld J; Gräber S; Brittner B; Bohle RM; Schilling MK
    BMC Cancer; 2008 Jun; 8():178. PubMed ID: 18578857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies.
    Oliveira Frick V; Rubie C; Ghadjar P; Faust SK; Wagner M; Gräber S; Schilling MK
    Tumour Biol; 2011 Feb; 32(1):189-96. PubMed ID: 20865359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential CXC receptor expression in colorectal carcinomas.
    Rubie C; Kollmar O; Frick VO; Wagner M; Brittner B; Gräber S; Schilling MK
    Scand J Immunol; 2008 Dec; 68(6):635-44. PubMed ID: 18959627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR6/CCL20 chemokine expression profile in distinct colorectal malignancies.
    Frick VO; Rubie C; Kölsch K; Wagner M; Ghadjar P; Graeber S; Glanemann M
    Scand J Immunol; 2013 Sep; 78(3):298-305. PubMed ID: 23790181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.
    Rubie C; Frick VO; Wagner M; Weber C; Kruse B; Kempf K; König J; Rau B; Schilling M
    World J Gastroenterol; 2006 Nov; 12(41):6627-33. PubMed ID: 17075975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer.
    Rubie C; Frick VO; Pfeil S; Wagner M; Kollmar O; Kopp B; Graber S; Rau BM; Schilling MK
    World J Gastroenterol; 2007 Oct; 13(37):4996-5002. PubMed ID: 17854143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an intermediate signature that marks the initial phases of the colorectal adenoma-carcinoma transition.
    Tang H; Guo Q; Zhang C; Zhu J; Yang H; Zou YL; Yan Y; Hong D; Sou T; Yan XM
    Int J Mol Med; 2010 Nov; 26(5):631-41. PubMed ID: 20878084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and gene polymorphisms of the chemokine CXCL5 in colorectal cancer patients.
    Dimberg J; Dienus O; Löfgren S; Hugander A; Wågsäter D
    Int J Oncol; 2007 Jul; 31(1):97-102. PubMed ID: 17549409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
    Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
    Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis.
    Furuya M; Suyama T; Usui H; Kasuya Y; Nishiyama M; Tanaka N; Ishiwata I; Nagai Y; Shozu M; Kimura S
    Hum Pathol; 2007 Nov; 38(11):1676-87. PubMed ID: 17707463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis.
    Rubie C; Oliveira V; Kempf K; Wagner M; Tilton B; Rau B; Kruse B; Konig J; Schilling M
    Tumour Biol; 2006; 27(3):166-74. PubMed ID: 16641550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
    Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
    Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectum.
    Cui G; Goll R; Olsen T; Steigen SE; Husebekk A; Vonen B; Florholmen J
    Cancer Immunol Immunother; 2007 Jul; 56(7):985-95. PubMed ID: 17160410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced ENA-78 and IL-8 expression in patients with malignant pancreatic diseases.
    Frick VO; Rubie C; Wagner M; Graeber S; Grimm H; Kopp B; Rau BM; Schilling MK
    Pancreatology; 2008; 8(4-5):488-97. PubMed ID: 18765953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP3 and CXCL1 are potent stromal protein markers of dysplasia-carcinoma transition in sporadic colorectal cancer.
    Sipos F; Germann TM; Wichmann B; Galamb O; Spisák S; Krenács T; Tulassay Z; Molnár B; Műzes G
    Eur J Cancer Prev; 2014 Sep; 23(5):336-43. PubMed ID: 24999605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue and serum galectin-1 expression in patients with colorectal carcinoma.
    Sheng TH; Rong LX; Li ZY; Bo J; Lei S
    Hepatogastroenterology; 2012; 59(114):389-94. PubMed ID: 22353504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence.
    Cui G; Yuan A; Goll R; Florholmen J
    Scand J Gastroenterol; 2012 Nov; 47(11):1304-12. PubMed ID: 22989213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
    Bièche I; Chavey C; Andrieu C; Busson M; Vacher S; Le Corre L; Guinebretière JM; Burlinchon S; Lidereau R; Lazennec G
    Endocr Relat Cancer; 2007 Dec; 14(4):1039-52. PubMed ID: 18045955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of contraction-inducible CXC chemokines and their roles in C2C12 myocytes.
    Nedachi T; Hatakeyama H; Kono T; Sato M; Kanzaki M
    Am J Physiol Endocrinol Metab; 2009 Oct; 297(4):E866-78. PubMed ID: 19622786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of MEK1 and DIAPH3 expression in colorectal adenoma-carcinoma sequence.
    Foda AAM; El-Hawary AK; Elnaghi K; Eldehna WM; Enan ET
    Tumour Biol; 2024; 46(1):1-11. PubMed ID: 38728194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.